Showing 1051-1060 of 3039 results for "".
How Dry Eye Disease Changed Optometry
https://modernod.com/topics/ocular-surface/how-dry-eye-disease-changed-optometry/39135/The secondary consequences of embracing optometry’s expertise.Telemedicine in Eye and Contact Lens Care
https://modernod.com/topics/business/telemedicine-in-eye-and-contact-lens-care/38197/Ensuring patient health and safety in the evolving digital health landscape.First Commerical Surgeries Performed with MacTel Therapy
https://modernod.com/podcasts/eyewire-news-the-podcast/first-commerical-surgeries-performed-with-mactel-therapy/37097/Charles Wykoff, MD, PhD, shares his experience performing the first commercial case for a patient with MacTel; VSY Biotechnology launches its Enova Hydrophobic IOLs with a new preloaded delivery system; and an app is launched that syncs AI directly to leading OCT devices. Learn more about your ad chGlaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-migs-technology-certified-in-europe-new-phase-3-data-for-presbyopia-drop/37091/Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.TFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug BVision Advocacy Leaders Speak Out Against Proposed NEI Cuts
https://modernod.com/podcasts/eyewire-news-the-podcast/vision-advocacy-leaders-speak-out-against-proposed-nei-cuts/39870/A proposal by the Trump Administration calls for cuts to the National Institutes of Health and consolidation of the federal government’s 27 institutes into just eight. This includes folding the National Eye Institute into a new broader institute on neuroscience and brain research. Ophthalmic leaders2024 Year in Review — Part 1
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-1/37064/In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout58. All About Refractive Surgeries with Dr. Aparna Patel
https://modernod.com/podcasts/four-eyes/58-all-about-refractive-surgeries-with-dr-aparna-patel/37008/Dr. Aparna Patel is a cornea, cataract, and refractive surgeon practicing in Kentucky. She joins the podcast to discuss the various types of refractive surgeries, what patients are best suited for the procedures, pre and post-op management, and how optometrists can co-manage with the surgeon.To learSystemic Disease and the Eye: Risks and Recommendations
https://modernod.com/topics/retina/systemic-disease-and-the-eye-risks-and-recommendations/48718/A guide to understanding the ocular complications of metabolic syndrome.Surprise Spikes
https://modernod.com/topics/glaucoma/surprise-spikes/39841/While rare, increases in IOP post-selective laser trabeculoplasty can occur and require prompt attention for the best long-term outcomes.
